| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Resignation of Officer
On May 13, 2022, Mario Ramos, Chief Financial
Officer and Chief Risk Officer of Evolv Technologies Holdings, Inc. (the “Company”), notified the Company of his decision to
resign from his position, effective May 31, 2022, to pursue another opportunity as Chief Executive Officer at a privately held financial
services company. The Company thanks Mr. Ramos for his leadership and contribution.
Appointment of Officer
On May 19, 2022, the Company announced that
Mark Donohue will succeed Mr. Ramos as the Company’s Chief Financial Officer, effective as of June 1, 2022.
Prior to joining the Company, Mr. Donohue,
48, served as Chief Financial Officer of Vestmark, Inc. (“Vestmark”), a provider of SaaS-based portfolio management and trading
tools for financial advisors and institutions where he oversaw Vestmark’s Financial Planning, Corporate Development, Accounting
and Investor Relation departments, from August 2018 to May 2022. Prior to his time at Vestmark, Mr. Donohue served at Rapid7, Inc. (“Rapid7”),
a provider of security analytics and automation, in several senior roles including Vice President of Finance, Corporate Development, and
Treasury & Investor Relations, from February 2016 to August 2018. Before his time at Rapid7, Mr. Donohue held multiple Director level
positions at Cisco Systems in which he was involved in strategy, finance and business operations and Starent Networks, Corp., in which
he was involved in investor relations and treasury roles, and held senior roles at International Data Corporation, Ferris Baker Watts
Inc., Teradyne, Inc. and Quantum Corporation. He earned a BS in Business Administration & Finance from the University of New Hampshire,
and received both his MBA and MS in Finance from Boston College’s Wallace E. Carroll Graduate School of Management.
There
are no arrangements or understandings between Mr. Donohue and any other person pursuant to which he was appointed as Chief Financial Officer.
Mr. Donohue does not have any family relationship with any director or other executive officer of the Company or any person nominated
or chosen by the Company to become a director or executive officer, and there are no transactions in which Mr. Donohue has an interest
requiring disclosure under Item 404(a) of Regulation S-K currently contemplated or since the beginning of the last fiscal year.
In
connection with Mr. Donohue’s appointment as the Company’s Chief Financial Officer, the Company and Mr. Donohue entered
into an executive employment agreement (the “Donohue Employment Agreement”), dated as of May 18, 2022, pursuant to which
Mr. Donohue is entitled to an annual base salary of $375,000 and an annual target incentive bonus of 50% of the base salary,
based on the achievement of the Company and individual annual performance goals. Pursuant to the Donohue Employment Agreement, if
Mr. Donohue’s employment is terminated by the Company without “cause” or by Mr. Donohue following his resignation
with “good reason” (each as defined in the Donohue Employment Agreement), he shall be entitled to: (1) continued payment
of his base salary for a period of 12 months, (2) payment of an amount equal to 100% of his current year target bonus, paid in a
lump sum within 60 days following his termination date, (3) payment of premiums for continued health benefits to him under COBRA for
up to 12 months following his termination, and (4) any vested options remaining exercisable for 12 months following his termination.
If Mr. Donohue’s employment is terminated without cause or if he resigns with good reason within one year following a
“change of control” (as defined in the Donohue Employment Agreement), he shall be entitled to the aforementioned
payments and benefits, except that any then-unvested outstanding equity awards will become vested in their entirety as of the last
day of his employment. Mr. Donohue’s benefits are conditioned, among other things, on his complying with customary restrictive
covenants and non-solicitation provisions under the Donohue Employment Agreement and timely signing a general release of claims in
our favor. In connection with his appointment as Chief Financial Officer, the Board of Directors of the Company (the
“Board”), upon the recommendation of the Compensation Committee, also approved a grant of restricted stock units to Mr.
Donohue under the Company’s 2021 Incentive Award Plan with an aggregate grant date fair value equal to $3,600,000, vesting in
equal annual installments on the first three anniversaries of the date of grant, which date shall be the first regularly scheduled
grant date after Mr. Donohue’s start date with the Company, subject to Mr. Donohue's continued employment with the Company. The Board, upon the recommendation of the Committee, has also
approved an additional grant of 2,000 performance-based restricted stock units, which will vest based on the achievement of the
Company’s 2022 bookings goal, with 50% of any earned award vesting on January 1, 2023 and 50% of any earned award vesting on
January 1, 2024, subject to Mr. Donohue’s continued employment with the Company.
In addition, Mr. Donohue will enter into an officer indemnification
agreement pursuant to which, among other things, the Company agrees to indemnify its officers and advance certain expenses to the fullest
extent permitted by applicable law.
The foregoing description of the Donohue Employment Agreement is not
complete and is qualified in its entirety by the full text of the Donohue Employment Agreement, a copy of which is filed herewith as Exhibit
10.1 and incorporated herein by reference.
